ArticleClinical obesity2026
The Association Between Obesity Class and Cause-Specific Mortality by Age and Sex in US Adults.
Article in Clinical obesity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To investigate differences in cause-specific mortality risks between obesity classes stratified by age and sex, using a nationally representative sample of the US population. Differences in mortality risk by standard body mass index (BMI) categories with examination of Obesity Classes I-III, stratified by age (less or more than 65 years) and sex were examined using Cox proportional hazard ratios with data from NHANES Continuous (1999-2018) with mortality follow-up through 31 December 2019. Among younger adults (< 65 years), Obesity Class III was associated with higher all-cause, cardiovascular, non-cardiovascular/non-cancer and diabetes-related mortality compared to Class I. Among older adults (≥ 65 years), there were fewer significant associations with only cardiovascular and diabetes-related mortality risks being elevated in men with Obesity Class III and none in women. There were no differences in mortality risks between Obesity Classes I and II, except for diabetes-related mortality in younger adults and older men. Obesity Class III is strongly associated with higher mortality risk in younger adults (< 65 years) and to a lesser degree in older adults (≥ 65 years). Mortality risks were generally similar between obesity Classes I and II. Therefore, younger adults under 65 years of age with severe obesity may benefit more from aggressive obesity management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.